MedPath

江苏润邦药业有限公司

Ownership
-
Established
2004-07-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

31

NMPA:31

Drug Approvals

Glucosamine Sulfate Capsules

Product Name
硫酸氨基葡萄糖胶囊
Approval Number
国药准字H20254076
Approval Date
May 13, 2025
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253788
Approval Date
Apr 1, 2025
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253787
Approval Date
Apr 1, 2025
NMPA

Diammonium Glycyrrhizinate Capsules

Product Name
甘草酸二铵胶囊
Approval Number
国药准字H20084616
Approval Date
Dec 25, 2023
NMPA

Lafutidine Tablets

Product Name
顺儒
Approval Number
国药准字H20061138
Approval Date
Jan 29, 2021
NMPA

Gatifloxacin Mesylate Dispersible Tablets

Product Name
邦加分宁
Approval Number
国药准字H20061045
Approval Date
Jan 29, 2021
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H32025403
Approval Date
Jun 22, 2020
NMPA

银杏叶片

Approval Number
国药准字Z20053913
Approval Date
Jun 22, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H32020660
Approval Date
Jun 22, 2020
NMPA

Azithromycin Tablets

Product Name
阿奇霉素片
Approval Number
国药准字H20057601
Approval Date
Jun 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.